Rangasamy L - Search Results

1

Can 3D-Printed Bioactive Glasses Be the Future of Bone Tissue Engineering?

Dukle A, Murugan D, Nathanael AJ, Rangasamy L, Oh TH. Dukle A, et al. Among authors: rangasamy l. Polymers (Basel). 2022 Apr 18;14(8):1627. doi: 10.3390/polym14081627. Polymers (Basel). 2022. PMID: 35458377 Free PMC article. Review.

2

A perspective to weaponize microRNAs against lung cancer.

Murugan D, Rangasamy L. Murugan D, et al. Among authors: rangasamy l. Noncoding RNA Res. 2022 Sep 29;8(1):18-32. doi: 10.1016/j.ncrna.2022.09.009. eCollection 2023 Mar. Noncoding RNA Res. 2022. PMID: 36262424 Free PMC article. Review.

3

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy.

Murugan D, Murugesan V, Panchapakesan B, Rangasamy L. Murugan D, et al. Among authors: rangasamy l. Cancers (Basel). 2022 Nov 4;14(21):5438. doi: 10.3390/cancers14215438. Cancers (Basel). 2022. PMID: 36358857 Free PMC article. Review.

4

Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics.

Jaisankar A, Krishnan S, Rangasamy L. Jaisankar A, et al. Among authors: rangasamy l. Anal Biochem. 2022 Oct 15;655:114874. doi: 10.1016/j.ab.2022.114874. Epub 2022 Aug 24. Anal Biochem. 2022. PMID: 36027971 Review.

5

Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells.

Zapico JM, Acosta L, Pastor M, Rangasamy L, Marquez-Cantudo L, Coderch C, Ortin I, Nicolau-Sanus M, Puchades-Carrasco L, Pineda-Lucena A, Majali-Martinez A, Ramos P, de Pascual-Teresa B, Ramos A. Zapico JM, et al. Among authors: rangasamy l. Int J Mol Sci. 2021 Sep 15;22(18):9976. doi: 10.3390/ijms22189976. Int J Mol Sci. 2021. PMID: 34576138 Free PMC article.

6

Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).

Rangasamy L, Geronimo BD, Ortín I, Coderch C, Zapico JM, Ramos A, de Pascual-Teresa B. Rangasamy L, et al. Molecules. 2019 Aug 16;24(16):2982. doi: 10.3390/molecules24162982. Molecules. 2019. PMID: 31426440 Free PMC article. Review.

7

New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.

Rangasamy L, Ortín I, Zapico JM, Coderch C, Ramos A, de Pascual-Teresa B. Rangasamy L, et al. ACS Med Chem Lett. 2020 Apr 7;11(5):713-719. doi: 10.1021/acsmedchemlett.9b00561. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435375 Free PMC article.

8

FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.

Orellana EA, Tenneti S, Rangasamy L, Lyle LT, Low PS, Kasinski AL. Orellana EA, et al. Among authors: rangasamy l. Sci Transl Med. 2017 Aug 2;9(401):eaam9327. doi: 10.1126/scitranslmed.aam9327. Sci Transl Med. 2017. PMID: 28768807 Free PMC article.

9

New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K⁺/H⁺ Exchange.

Rangasamy L, Chelvam V, Kanduluru AK, Srinivasarao M, Bandara NA, You F, Orellana EA, Kasinski AL, Low PS. Rangasamy L, et al. Bioconjug Chem. 2018 Apr 18;29(4):1047-1059. doi: 10.1021/acs.bioconjchem.7b00714. Epub 2018 Mar 2. Bioconjug Chem. 2018. PMID: 29446616 Free PMC article.

10

Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin.

Orellana EA, Abdelaal AM, Rangasamy L, Tenneti S, Myoung S, Low PS, Kasinski AL. Orellana EA, et al. Among authors: rangasamy l. Mol Ther Nucleic Acids. 2019 Jun 7;16:505-518. doi: 10.1016/j.omtn.2019.04.003. Epub 2019 Apr 11. Mol Ther Nucleic Acids. 2019. PMID: 31071527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page